1. Home
  2. DIN vs CLLS Comparison

DIN vs CLLS Comparison

Compare DIN & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dine Brands Global Inc.

DIN

Dine Brands Global Inc.

HOLD

Current Price

$35.24

Market Cap

491.1M

ML Signal

HOLD

Logo Cellectis S.A.

CLLS

Cellectis S.A.

HOLD

Current Price

$3.53

Market Cap

438.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DIN
CLLS
Founded
1958
1999
Country
United States
France
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
491.1M
438.4M
IPO Year
1991
2007

Fundamental Metrics

Financial Performance
Metric
DIN
CLLS
Price
$35.24
$3.53
Analyst Decision
Hold
Strong Buy
Analyst Count
6
2
Target Price
$31.67
$8.50
AVG Volume (30 Days)
404.1K
41.5K
Earning Date
03-04-2026
03-12-2026
Dividend Yield
2.18%
N/A
EPS Growth
N/A
N/A
EPS
2.24
N/A
Revenue
$866,500,000.00
$82,551,000.00
Revenue This Year
$10.69
$32.58
Revenue Next Year
$2.20
$20.68
P/E Ratio
$15.59
N/A
Revenue Growth
6.47
129.04
52 Week Low
$18.63
$1.10
52 Week High
$39.68
$5.48

Technical Indicators

Market Signals
Indicator
DIN
CLLS
Relative Strength Index (RSI) 52.93 33.51
Support Level $33.71 $4.04
Resistance Level $36.06 $3.95
Average True Range (ATR) 1.36 0.21
MACD -0.28 -0.07
Stochastic Oscillator 29.95 8.05

Price Performance

Historical Comparison
DIN
CLLS

About DIN Dine Brands Global Inc.

Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: